Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery

Acta Biomaterialia(2020)10.1016/j.actbio.2020.05.026Source: DataRank Database

Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery is a research paper published in Acta Biomaterialia (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.77)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jiawei Chen ORCID,Nicholas Little,Jianqin Lu ORCID,Zhiren Wang ORCID

Live enrichment

PubMed:32454086 PMC:PMC7245299 OpenAlex:https://openalex.org/W3026714337

National Institutes of Health

Grant: P30 ES006694

National Institutes of Health

Grant: R35 ES031575

University of Arizona

FWCI

2.77

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S1742706120302968-fx1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1742706120302968-fx1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1742706120302968?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706120302968?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.actbio.2020.05.026

Fields of Study

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene Delivery

MeSH Terms

Antineoplastic AgentsDrug CarriersHumansNeoplasmsProdrugsDrug Delivery SystemsCell Line, TumorNanoparticlesDrug Liberation

Keywords

ProdrugDrug deliveryDrugPharmacologyPEGylationTargeted drug deliveryNanocarriersMedicineNanotechnologyChemistryMaterials sciencePolyethylene glycolBiochemistryNanotherapeuticsSelf-assembling ProdrugSynergistic Drug DeliveryEnhanced Cancer Therapy

Sustainable Development Goals

SDG 0: Good health and well-being